Korean Medical Product Maker Ends Bid For Trimeris
DURHAM, N.C. (AP) ¿ Arigene Co., a Korean medical equipment maker, said Tuesday it is terminating its tender offer for outstanding shares of biopharmaceutical company Trimeris Inc.
Arigene couldn't secure enough financing for the offer, the company said.
Trimeris agreed to be acquired on Oct. 2 for about $81 million, or $3.60 per share, and the tender offer was extended until Monday on Nov. 17. Arigene had asked for another extension but Trimeris didn't grant it.
When the offer expired Monday, about 19.3 million, or 86.4 percent of outstanding Trimeris shares, had been tendered. Arigene said the tendered shares will be returned to their holders.The news sent Trimeris shares down 54 cents, or 17 percent, to $2.64. The stock has traded between 84 cents and $3.68 over the past year.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV